95 related articles for article (PubMed ID: 79534)
1. [Studies of 57-co-bleomycin in patients with carcinoma colli uteri (author's transl)].
Schober O; Mariss P; Pertynski T; Zimmermann P; Börner P
Rofo; 1978 Jun; 128(6):754-7. PubMed ID: 79534
[TBL] [Abstract][Full Text] [Related]
2. Radiation absorbed doses from Co-57- and Co-55 bleomycin.
Beekhuis H; Nieweg OE
J Nucl Med; 1984 Apr; 25(4):478-85. PubMed ID: 6085803
[TBL] [Abstract][Full Text] [Related]
3. [Investigations on the accumulation of radio-bleomycin in gynaecological tumors (author's transl)].
Lange J; Lange S; Kreuzer G; Haubold U
Geburtshilfe Frauenheilkd; 1976 May; 36(5):436-8. PubMed ID: 58804
[TBL] [Abstract][Full Text] [Related]
4. [Influence of radiotherapy upon tumor accumulation and organ distribution of 57Co-bleomycin in mice with chemically induced squamous cell carcinoma (author's transl)].
Pertynski T; Ketkar MB; Mariss P; Reznik G; Hassenstein E; Nüsslin F; Dieffenbach G; Haindl H
Strahlentherapie; 1979 Nov; 155(11):770-3. PubMed ID: 92831
[TBL] [Abstract][Full Text] [Related]
5. [Distribution of various 57Co-labelled zhengguangmycin preparations in Ehrlich carcinoma bearing mice in relation with their antitumor activity and toxicity (author's transl)].
Xue SB; Liu HT; Zhang HQ; Li DD; Lin HY
Yao Xue Xue Bao; 1980 Jan; 15(1):1-6. PubMed ID: 6161520
[No Abstract] [Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
7. [Distribution studies of 111In labeled bleomycin in the intratumoral and peritumoral treatment of advanced squamous cell carcinomas in the oto-rhino-larygnological region (author's transl)].
Glasowski P; Zambelis N
Laryngol Rhinol Otol (Stuttg); 1978 May; 57(5):472-4. PubMed ID: 77462
[TBL] [Abstract][Full Text] [Related]
8. The influence of chemotherapy on the distribution of 57Co-bleomycin in chemically induced squamous cell carcinoma of mouse skin.
Pertynski T; Reznik G; Mariss P; Ketkar MB; Haindl H; Dieffenbach G
Eur J Nucl Med; 1979 Feb; 4(1):55-9. PubMed ID: 91511
[TBL] [Abstract][Full Text] [Related]
9. [Effects of conformation radiotherapy combined with daily intramuscular injection of bleomycin for uterine cervical cancer (author's transl)].
Mimura M; Ishigaki T; Niwa K; Ishikawa T; Toyama J; Banno T; Mizutani M; Makino N; Mizutani H; Kamata N; Imagunbai N; Sakuma S; Koike K; Yagami Y
Rinsho Hoshasen; 1980 Nov; 25(12):1311-6. PubMed ID: 6162043
[No Abstract] [Full Text] [Related]
10. Some experience with 57Co-labeled bleomycin as a tumor-seeking agent.
Rasker JJ; Poll AM; Beekhuis H; Woldring MG; Nieweg HO
J Nucl Med; 1975 Nov; 16(11):1058-69. PubMed ID: 52700
[TBL] [Abstract][Full Text] [Related]
11. [Distribution study using 57Co-, 51Cr-, 111In- and 99mTc-bleomycin in mice with a solid Ehrlich carcinoma].
Zimmermann M; Hale T
Nuklearmedizin; 1976 Aug; 15(4):176-82. PubMed ID: 62345
[TBL] [Abstract][Full Text] [Related]
12. Intracellular distribution of 57Co-bleomycin.
Konings AW; Rasker JJ; Posthuma GA
Curr Top Radiat Res Q; 1978 Jan; 12(1-4):497-512. PubMed ID: 76527
[TBL] [Abstract][Full Text] [Related]
13. [Comparative studies on the uptake and organ distribution of 57Co-bleomycin and 57Co-bleomycin-A2 in mice with squamous cell tumors of the skin and vagina].
Pertynski T; Ketkar MB; Mariss P; Reznik G; Talas A; Dieffenbach G
Nuklearmedizin; 1979; 18(6):300-3. PubMed ID: 94162
[No Abstract] [Full Text] [Related]
14. Uptake of labelled tallysomycin by solid Ehrlich ascites tumors in mice.
Liniecki J; Rembelska M; Koniarek B
Nuklearmedizin; 1983 Jun; 22(3):159-61. PubMed ID: 6194513
[TBL] [Abstract][Full Text] [Related]
15. Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice.
Krohn KA; Meyers JM; DeNardo GL; DeNardo SJ
J Nucl Med; 1977 Mar; 18(3):276-81. PubMed ID: 65460
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the administration of bleomycin in a nude mouse model of squamous cell carcinoma of the mouth. 1. 57Co-bleomycin pharmacokinetics after intratumor and intravenous administration].
Henke E; Fröhlich M; Gens J; Arnold W; Naundorf A; Franke WG; Seela W
Radiobiol Radiother (Berl); 1984; 25(1):143-52. PubMed ID: 6203135
[No Abstract] [Full Text] [Related]
17. [Investigations on the use of 57Co-bleomycin for evaluating the extent of the malignant process in patients with cervical cancer (author's transl)].
Pertyński T; Durski K; Babińska E; Dyktyńska A
Pol Przegl Radiol Med Nukl; 1979; 43(5):286-8. PubMed ID: 94434
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics and dosimetry of cobalt-55 and cobalt-57.
Jansen HM; Knollema S; van der Duin LV; Willemsen AT; Wiersma A; Franssen EJ; Russel FG; Korf J; Paans AM
J Nucl Med; 1996 Dec; 37(12):2082-6. PubMed ID: 8970539
[TBL] [Abstract][Full Text] [Related]
19. [57Co-bleomycin kinetics after local and systemic administration].
Bier J; Benders P; Bitter K
Dtsch Zahnarztl Z; 1980 Jan; 35(1):96-8. PubMed ID: 6157513
[TBL] [Abstract][Full Text] [Related]
20. [Chemical properties and tumor affinity of separated isomers of cobalt-bleomycin (author's transl)].
Kakinuma J; Samezima K; Nakamura K; Kawaguchi H; Komine K; Orii H
Kaku Igaku; 1981 Jul; 18(6):835-9. PubMed ID: 6171664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
